BGB-8035
BGB-8035 is a potent, selective, and orally bioavailable small molecule inhibitor targeting BTK, with additional activity against TEC and EGFR kinases. It is utilized in preclinical research for oncology and autoimmune diseases, demonstrating antitumor efficacy in both cellular assays and animal models.
Product Specifications
CAS Number
2283349-24-4
Product Name Alternative
BGB 8035, BGB8035, BTK, TEC
Field of Research
Cardiovascular Research, Signal Transduction
Purity
96.74% (May vary between batches)
Smiles
C (N) (=O) C1=C2N ([C@@H] (CCN2) C3CCN (C (C=C) =O) CC3) N=C1C4=CC (OC) =C (C) C (OC) =C4
Molecular Formula
C24H31N5O4
Molecular Weight
453.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog